Teva Pharmaceutical Industries (TEVA): Debt to Book Capitalization Ratio

Volatility of Teva Pharmaceutical Industries (TEVA) shares is mitigated by its status as a global leader in the affordable generics sector. The ratio of attracted funds to book capitalization helps track leverage, where the 2.21 mark serves as the current indicator. The brand's survival relies on massive sales volumes despite low margins, while a steady cash flow ensures the stability of operating income.

For the global generics and biosimilars leader Teva Pharmaceutical Industries (TEVA), this ratio determines the degree of business dependence on borrowed funds relative to equity. By analyzing total debt to book capitalization on the GURU.Markets platform, an investor assesses the stability of the leverage, which is critical for sustaining expansion in neurology and ensuring the long-term solvency of Teva Pharmaceutical Industries (TEVA).